Amphastar Pharmaceuticals
AMPH
$42.33
Share price
0.43%
Change (1 day)
-6.23%
Change (1 year)
Categories
Market capitalization of Amphastar Pharmaceuticals (AMPH)
Market cap: $2.07 Billion
As of June 2024 Amphastar Pharmaceuticals has a market cap of $2.07 Billion. This makes Amphastar Pharmaceuticals the world's 4072th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Amphastar Pharmaceuticals from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.07 B | -30.14% |
| 2023 | $2.96 B | 118.8% |
| 2022 | $1.35 B | 21.52% |
| 2021 | $1.11 B | 16.68% |
| 2020 | $0.95 B | 6.31% |
| 2019 | $0.89 B | -3.18% |
| 2018 | $0.92 B | 4.9% |
| 2017 | $0.88 B | 4.34% |
| 2016 | $0.84 B | 31.81% |
| 2015 | $0.64 B | 24.08% |
| 2014 | $0.51 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Amphastar Pharmaceuticals was reported to be:
$2.07 Billion
$2.07 Billion
$2.07 Billion
$2.07 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | $15.56 M | -99.25% | 🇺🇸 USA |
 SCYNEXIS SCYX | $91.23 M | -95.59% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | $78 M | -96.23% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.47 M | -99.88% | 🇺🇸 USA |